Tim Elliott Selected Research

Orofacial Granulomatosis

1/2020	Using Ustekinumab to Treat Crohn's Disease-Related Orofacial Granulomatosis: Two Birds, One Stone.
1/2011	Experience with anti-TNF-α therapy for orofacial granulomatosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tim Elliott Research Topics

Disease

13	Neoplasms (Cancer) 01/2021 - 11/2002
7	Infections 01/2022 - 06/2004
4	Skin Neoplasms (Skin Cancer) 08/2012 - 01/2004
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2004
3	Crohn Disease (Crohn's Disease) 01/2020 - 10/2008
2	Orofacial Granulomatosis 01/2020 - 01/2011
2	Ankylosing Spondylitis 12/2014 - 02/2014
2	Melanoma (Melanoma, Malignant) 11/2011 - 01/2004
1	Human Influenza (Influenza) 01/2022
1	Hypersensitivity (Allergy) 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2020
1	Dehydration (Water Stress) 10/2019
1	AIDS-Related Complex (ARC) 10/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Malaria 11/2018
1	Necrosis 01/2017
1	Disease Progression 10/2011
1	Virus Diseases (Viral Diseases) 10/2011
1	Fistula 10/2008
1	Carcinoma (Carcinomatosis) 04/2007
1	Breast Neoplasms (Breast Cancer) 01/2007
1	Testicular Neoplasms (Testicular Cancer) 01/2007
1	Vaccinia 01/2006
1	Erythema 01/2004
1	Bowen's Disease (Disease, Bowen) 01/2004
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2004
1	Pain (Aches) 01/2004
1	Autoimmune Diseases (Autoimmune Disease) 11/2002

Drug/Important Bio-Agent (IBA)

10	Peptides (Polypeptides)IBA 01/2022 - 02/2008
6	Histocompatibility Antigens Class IIBA 01/2021 - 02/2008
5	VaccinesIBA 01/2022 - 06/2004
5	AntigensIBA 10/2020 - 11/2002
4	EpitopesIBA 01/2022 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2015
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 12/2019
2	Neoplasm Antigens (Tumor Antigens)IBA 12/2019 - 11/2002
2	Glycoproteins (Glycoprotein)IBA 12/2019 - 04/2007
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 12/2014 - 02/2014
2	LigandsIBA 09/2012 - 02/2008
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2022
1	Immunodominant EpitopesIBA 01/2022
1	PiperazineIBA 10/2021
1	FenbendazoleIBA 10/2021
1	Levamisole (Decaris)FDA Link 10/2021
1	abacavir (Ziagen)FDA Link 01/2021
1	HLA-B57 antigenIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	tapasinIBA 11/2020
1	Ustekinumab (CNTO 1275)FDA Link 01/2020
1	MolybdenumIBA 10/2019
1	serpentine (alkaloid)IBA 10/2019
1	Complement System Proteins (Complement)IBA 10/2019
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 11/2018
1	Histocompatibility Antigens Class IIIBA 11/2018
1	AnthelminticsIBA 07/2017
1	InterferonsIBA 01/2017
1	CytokinesIBA 01/2017
1	AminopeptidasesIBA 02/2014
1	Arginine (L-Arginine)FDA Link 02/2014
1	leucinethiolIBA 06/2013
1	Viral AntigensIBA 09/2012
1	Neuraminidase (Sialidase)IBA 09/2012
1	SteroidsIBA 10/2008
1	Infliximab (Remicade)FDA Link 10/2008
1	Thioguanine (Tioguanine)FDA Link 10/2008
1	NK Cell Lectin-Like Receptor Subfamily CIBA 01/2006
1	DNA VaccinesIBA 06/2004
1	Monoclonal AntibodiesIBA 01/2004
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2004
1	AutoantigensIBA 11/2002

Therapy/Procedure

3	Mohs Surgery (Mohs' Micrographic Surgery) 08/2012 - 05/2011
2	Therapeutics 06/2013 - 01/2011
1	Immunotherapy 06/2013
1	Lasers (Laser) 05/2011
1	Aftercare (After-Treatment) 01/2004
1	Photochemotherapy (Photodynamic Therapy) 01/2004
1	Analgesia 01/2004